+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-10-31Number of Pages: 124

Cancer Diagnostics Market (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

 

Chapter 1 Introduction

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

     1.3.1 Assumptions and Stipulations

1.4 List of Abbreviations

 

Chapter 2 Executive Summary

2.1 Global Cancer Diagnostics Market, by Application, 2013 (USD Million)

2.2 Comparative Analysis: Global Cancer Diagnostics Market, By Geography, 2013 & 2020 (Value %)

 

Chapter 3 Market Overview

3.1 Market Definition and Overview

3.2 Risk Factors, Prognosis and Recurrence of Different Cancers

     3.2.1 Risk Factors 

     3.2.2 Recurrence and Prognosis of Cancer

     3.2.3 Market Trends and Future Outlook

     3.2.4 Regulatory Scenario

3.3 Market Dynamics

     3.3.1 Market Drivers

             3.3.1.1 Rising Prevalence of Cancer Drives Demand for Cancer Diagnostics

             3.3.1.2 Early Diagnosis Crafts Better Clinical and Economical Outcomes

             3.3.1.3 Novel Diagnostic Biomarkers Continues To Create New Revenue Stream

     3.3.2 Market Restraints

             3.3.2.1 Lack of Sensitivity and Specificity

             3.3.2.2 Uncertain Reimbursement Scenario Limits Market Growth

     3.3.3 Opportunity

             3.3.3.1 Introduction of Non-invasive and Safe Cancer Screening Methods

3.4 Porter’s Five Force Analysis

     3.4.1 Bargaining Power of Buyers

     3.4.2 Bargaining Power of Suppliers

     3.4.3 Threat of New Entrants

     3.4.4 Threat of Substitutes

     3.4.5 Competitive Rivalry

3.5 Event Impact Analysis

3.6 Market Attractiveness

     3.6.1 Market Attractiveness Analysis: Global Cancer Diagnostics Market, By Method, 2013 & 2020 (Value %)

3.7 Competitive Landscape

     3.7.1 Cancer Diagnostics Market: Global Market Share by Key Players, IVDs, Molecular Diagnostics and Companion Diagnostics), 2013 (Value %)

     3.7.2 Cancer Diagnostics Market: Global Market Share by Key Players (Imaging Equipment Manufacturers), 2013 (Value %)

 

Chapter 4 Global Cancer Diagnostics Market, by Methods

4.1 Overview

     4.1.1 Global Cancer Diagnostics Market Revenue, by Method, 2012-2020 (USD Million)

     4.1.2 Comparative analysis: Global Cancer Diagnostics Market, by Methods, 2013 & 2020 (Value %)

4.2 Tumor Biomarker Tests

     4.2.1 Prostate Specific Antigen Tests

             4.2.1.1 Global Prostate Specific Antigen Tests Market Revenue, 2012-2020 (USD Million)

     4.2.2 Circulating Tumor Cells (CTC) Tests

             4.2.2.1 Global Circulating Tumor Cells (CTC) Tests Market Revenue, 2012-2020 (USD Million)

     4.2.3 Alpha-Fetoprotein (AFP) Tests

             4.2.3.1 Global Alpha-Fetoprotein (AFP) Tests Market Revenue, 2012-2020 (USD Million)

     4.2.4 CA 19-9 Tests

             4.2.4.1 Global CA 19-9 Tests Market Revenue, 2012-2020 (USD Million)

     4.2.5 CA 125 Tests

             4.2.5.1 Global CA 125 Tests Market Revenue, 2012-2020 (USD Million)

     4.2.6 EGFR Mutation Tests

             4.2.6.1 Global EGFR Mutation Tests Market Revenue, 2012-2020 (USD Million)

     4.2.7 HER2 Tests

             4.2.7.1 Global HER2 Tests Market Revenue, 2012-2020 (USD Million)

     4.2.8 Carcinoembryonic Antigen (CEA) Tests

             4.2.8.1 Global Carcinoembryonic Antigen (CEA) Tests Market Revenue, 2012-2020 (USD Million)

     4.2.9 BRCA Tests

             4.2.9.1 Global BRCA Tests Market Revenue, 2012-2020 (USD Million)

     4.2.10 KRAS Mutation Tests

              4.2.10.1 Global KRAS Mutation Tests Market Revenue, 2012-2020 (USD Million)

     4.2.11 Anaplastic Lymphoma Kinase (ALK) Tests

              4.2.11.1 Global Anaplastic Lymphoma Kinase (ALK) Tests Market Revenue, 2012-2020 (USD Million)

4.3 Imaging

     4.3.1 Magnetic Resonance Imaging (MRI) Scan

             4.3.1.1 MRI Scan Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

     4.3.2 Positron Emission Tomography (PET) Scan

             4.3.2.1 PET Scan Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)

     4.3.3 Computed Tomography (CT) Scan

             4.3.3.1 CT Scan Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)

     4.3.4 Mammography

             4.3.4.1 Mammography Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)

     4.3.5 Ultrasound

             4.3.5.1 Ultrasound Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)

4.4 Endoscopy

     4.4.1 Colonoscopy

             4.4.1.1 Global Colonoscopy Tests Market Revenue, 2012-2020 (USD Million)

     4.4.2 Sigmoidoscopy

             4.4.2.1 Global Sigmoidoscopy Tests Market Revenue, 2012-2020 (USD Million)

     4.4.3 Bronchoscopy

             4.4.3.1 Global Bronchoscopy Tests Market Revenue, 2012-2020 (USD Million)

     4.4.4 Colposcopy

              4.4.4.1 Global Colposcopy Tests Market Revenue, 2012-2020 (USD Million)

     4.4.5 Other Endoscopy

             4.4.5.1 Global Other Endoscopy Tests Market Revenue, 2012-2020 (USD Million)

4.5 Biopsy

     4.5.1 Bone Marrow Biopsy

             4.5.1.1 Global Bone Marrow Biopsy Tests Market Revenue, 2012-2020 (USD Million)

     4.5.2 Needle Biopsy

             4.5.2.1 Global Needle Biopsy Tests Market Revenue, 2012-2020 (USD Million)

     4.5.3 Endoscopic Biopsy

             4.5.3.1 Global Endoscopic Biopsy Tests Market Revenue, 2012-2020 (USD Million)

 

Chapter 5 Global Cancer Diagnostics Market, by Applications

5.1 Overview

     5.1.1 Global Cancer Diagnostics Market Revenue, by Applications Geography, 2012-2020 (USD) Million

     5.1.2 Comparative analysis: Global Cancer Diagnostics Market, by Applications, 2013 & 2020 (Value %)

5.2 Blood Cancer

     5.2.1 Blood Cancer: Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)

     5.2.2 Global Blood Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

5.3 Breast Cancer

     5.3.1 Breast Cancer: Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)

     5.3.2 Global Breast Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

5.4 Colorectal Cancer (CRC)

     5.4.1 Colorectal Cancer: Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)

     5.4.2 Global Colorectal Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

5.5 Kidney Cancer

     5.5.1 Kidney Cancer : Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)

     5.5.2 Global Kidney Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

5.6 Liver Cancer

     5.6.1 Liver Cancer : Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)

     5.6.2 Global Liver Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

5.7 Lung Cancer

     5.7.1 Lung Cancer : Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)

     5.7.2 Global Lung Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

5.8 Ovarian Cancer

     5.8.1 Ovarian Cancer : Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)

     5.8.2 Global Ovarian Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

5.9 Pancreatic Cancer

     5.9.1 Pancreatic Cancer : Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)

     5.9.2 Global Pancreatic Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

5.10 Prostate Cancer

     5.10.1 Prostate Cancer : Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)

     5.10.2 Global Prostate Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

 

Chapter 6 Global Cancer Diagnostics Market, by Geography

6.1 Overview

     6.1.1 Global Cancer Diagnostics Market Revenue, by Geography, 2012-2020 (USD) Million

     6.1.2 Comparative Analysis: Global Cancer Diagnostics Market by Geography, 2013 & 2020 (Value %)

6.2 North America

     6.2.1 North America Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

6.3 Europe

     6.3.1 Europe Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

6.4 Asia Pacific

     6.4.1 Asia Pacific Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

6.5 Rest of the World (RoW)

     6.5.1 Rest of the World Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

 

Chapter 7 Company Profiles

7.1 Abbott Laboratories, Inc.

     7.1.1 Company Overview

     7.1.2 Financial Overview

     7.1.3 Product Portfolio

     7.1.4 Business Strategies

     7.1.5 Recent Developments

7.2 Ambry Genetics

     7.2.1 Company Overview

     7.2.2 Financial Overview

     7.2.3 Product Portfolio

     7.2.4 Business Strategies

     7.2.5 Recent Developments

7.3 AstraZeneca plc

     7.3.1 Company Overview

     7.3.2 Financial Overview

     7.3.3 Product Portfolio

     7.3.4 Business Strategies

     7.3.5 Recent Developments

7.4 bioMeriux SA

     7.4.1 Company Overview

     7.4.2 Financial Overview

     7.4.3 Product Portfolio

     7.4.4 Business Strategies

     7.4.5 Recent Developments

7.5 Eli Lilly and Company

     7.5.1 Company Overview

     7.5.2 Financial Overview

     7.5.3 Product Portfolio

     7.5.4 Business Strategies

     7.5.5 Recent Developments

7.6 Genoptix, Inc.

     7.6.1 Company Overview

     7.6.2 Financial Overview

     7.6.3 Product Portfolio

     7.6.4 Business Strategies

     7.6.5 Recent Developments

7.7 GlaxoSmithKline plc

     7.7.1 Company Overview

     7.7.2 Financial Overview

     7.7.3 Product Portfolio

     7.7.4 Business Strategies

     7.7.5 Recent Developments

7.8 F. Hoffmann-La Roche Ltd.

     7.8.1 Company Overview

     7.8.2 Financial Overview

     7.8.3 Product Portfolio

     7.8.4 Business Strategies

     7.8.5 Recent Developments

7.9 Pfizer, Inc.

     7.9.1 Company Overview

     7.9.2 Financial Overview

     7.9.3 Product Portfolio

     7.9.4 Business Strategies

     7.9.5 Recent Developments

List of Figures

 

FIG. 1 Global and U.S. Cancer Biomarker Blood Tests Market Segmentation

FIG. 2 Global Cancer Diagnostics Market, by Application, 2013 (USD Million)

FIG. 3 Comparative Analysis: Global Cancer Diagnostics Market, by Geography, 2013 & 2020E (Value %)

FIG. 4 Porter’s Five Forces Analysis: Global Cancer Diagnostics Market

FIG. 5 Market Attractiveness Analysis: Global Cancer Diagnostics Market, By Method, 2013 & 2020 (Value %)

FIG. 6 Cancer Diagnostics Market: Global Market Share by Key Players, IVDs, Molecular Diagnostics and Companion Diagnostics), 2013 (Value %)

FIG. 7 Cancer Diagnostics Market: Global Market Share by Key Players, 2013 (Value %)

FIG. 8 Comparative analysis: Global Cancer Diagnostics Market, by Methods, 2013 & 2020 (Value %)

FIG. 9 Global Prostate Specific Antigen Tests Market Revenue, 2012-2020 (USD Million)

FIG. 10 Global Circulating Tumor Cells (CTC) Tests Market Revenue, 2012-2020 (USD Million)

FIG. 11 Global Alpha-Fetoprotein (AFP) Tests Market Revenue, 2012-2020 (USD Million)

FIG. 12 Global CA 19-9 Tests Market Revenue, 2012-2020 (USD Million)

FIG. 13 Global CA 19-9 Tests Market Revenue, 2012-2020 (USD Million)

FIG. 14 Global EGFR Mutation Tests Market Revenue, 2012-2020 (USD Million)

FIG. 15 Global HER2 Tests Market Revenue, 2012-2020 (USD Million)

FIG. 16 Global Carcinoembryonic Antigen (CEA) Tests Market Revenue, 2012-2020 (USD Million)

FIG. 17 Global BRCA Tests Market Revenue, 2012-2020 (USD Million)

FIG. 18 Global KRAS Mutation Tests Market Revenue, 2012-2020 (USD Million)

FIG. 19 Global Anaplastic Lymphoma Kinase (ALK) Tests Market Revenue, 2012-2020 (USD Million)

FIG. 20 MRI Scan Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)

FIG. 21 PET Scan Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)

FIG. 22 CT Scan Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)

FIG. 23 Mammography Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)

FIG. 24 Ultrasound Cancer Diagnosis Market Revenue, 2012-2020 (USD Million)

FIG. 25 Global Colonoscopy Tests Market Revenue, 2012-2020 (USD Million)

FIG. 26 Global Sigmoidoscopy Tests Market Revenue, 2012-2020 (USD Million)

FIG. 27 Global Bronchoscopy Tests Market Revenue, 2012-2020 (USD Million)

FIG. 28 Global Colposcopy Tests Market Revenue, 2012-2020 (USD Million)

FIG. 29 Global Other Endoscopy Tests Market Revenue, 2012-2020 (USD Million)

FIG. 30 Global Bone Marrow Biopsy Tests Market Revenue, 2012-2020 (USD Million)

FIG. 31 Global Needle Biopsy Tests Market Revenue, 2012-2020 (USD Million)

FIG. 32 Global Endoscopic Biopsy Tests Market Revenue, 2012-2020 (USD Million)

FIG. 33 Comparative analysis: Global Cancer Diagnostics Market, by Applications, 2013 & 2020 (Value %)

FIG. 34 Blood Cancer: Estimated number of new cases, all ages, both sexes (2012, 2015 & 2020)

FIG. 35 Global Blood Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

FIG. 52 Comparative Analysis: Global Cancer Diagnostics Market, By Geography, 2013 & 2020 (Value %)

FIG. 53 North America Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

FIG. 54 Europe Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

FIG. 55 Asia Pacific Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

FIG. 56 Asia Pacific Cancer Diagnostics Market Revenue, 2012-2020 (USD Million)

FIG. 57 Abbott Laboratories : Annual Revenue, 2011 – 2013 (USD Million)

FIG. 58 Astra Zeneca plc: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 59 bioMeriux SA : Annual Revenue, 2011 – 2013 (USD Million)

FIG. 60 Eli Lilly and Company: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 61 GlaxoSmithKline plc: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 62 F. Hoffmann-La Roche Ltd: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 63 Pfizer, Inc.: Annual Revenue, 2011 – 2013 (USD Million)

List of Tables

 

TABLE 1 List of Abbreviation

TABLE 2 Market Snapshot: Global Cancer Diagnostics Market

TABLE 3 List of Cancer Risk Factors

TABLE 4 Estimated Incidence, and 1 year, 2 years and 5 years survival

TABLE 5 Breast Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs

TABLE 6 Lung Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs

TABLE 7 Colorectal Cancer Companion Diagnostics (CDx), Manufacturers and Target Drugs

TABLE 8 Summary of Type of Diagnostics Test in the U.S.

TABLE 9 Event Impact Analysis: Global Cancer Diagnostics Market, 2012-2020

TABLE 10 Global Cancer Diagnostics Market Revenue, by Method, 2012-2020 (USD) Million

TABLE 11 Global Cancer Diagnostics Market Revenue, by Applications, 2012-2020 (USD) Million

TABLE 12 Global Cancer Diagnostics Market Revenue, by Geography, 2012-2020 (USD) Million


 
 
Back To Top